366 related articles for article (PubMed ID: 24695755)
1. Advances in the molecular design of potential anticancer agents via targeting of human telomeric DNA.
Maji B; Bhattacharya S
Chem Commun (Camb); 2014 Jun; 50(49):6422-38. PubMed ID: 24695755
[TBL] [Abstract][Full Text] [Related]
2. Symmetrical bisbenzimidazoles with benzenediyl spacer: the role of the shape of the ligand on the stabilization and structural alterations in telomeric G-quadruplex DNA and telomerase inhibition.
Bhattacharya S; Chaudhuri P; Jain AK; Paul A
Bioconjug Chem; 2010 Jul; 21(7):1148-59. PubMed ID: 20536245
[TBL] [Abstract][Full Text] [Related]
3. Affinity and selectivity of G4 ligands measured by FRET.
De Cian A; Guittat L; Shin-ya K; Riou JF; Mergny JL
Nucleic Acids Symp Ser (Oxf); 2005; (49):235-6. PubMed ID: 17150720
[TBL] [Abstract][Full Text] [Related]
4. Targeting telomeres and telomerase.
De Cian A; Lacroix L; Douarre C; Temime-Smaali N; Trentesaux C; Riou JF; Mergny JL
Biochimie; 2008 Jan; 90(1):131-55. PubMed ID: 17822826
[TBL] [Abstract][Full Text] [Related]
5. Telomere maintenance as a target for drug discovery.
Sekaran V; Soares J; Jarstfer MB
J Med Chem; 2014 Feb; 57(3):521-38. PubMed ID: 24053596
[TBL] [Abstract][Full Text] [Related]
6. Rational design of acridine-based ligands with selectivity for human telomeric quadruplexes.
Sparapani S; Haider SM; Doria F; Gunaratnam M; Neidle S
J Am Chem Soc; 2010 Sep; 132(35):12263-72. PubMed ID: 20718414
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for telomeric G-quadruplex targeting by naphthalene diimide ligands.
Collie GW; Promontorio R; Hampel SM; Micco M; Neidle S; Parkinson GN
J Am Chem Soc; 2012 Feb; 134(5):2723-31. PubMed ID: 22280460
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence-based melting assays for studying quadruplex ligands.
De Cian A; Guittat L; Kaiser M; Saccà B; Amrane S; Bourdoncle A; Alberti P; Teulade-Fichou MP; Lacroix L; Mergny JL
Methods; 2007 Jun; 42(2):183-95. PubMed ID: 17472900
[TBL] [Abstract][Full Text] [Related]
9. Reduced or diminished stabilization of the telomere G-quadruplex and inhibition of telomerase by small chemical ligands under molecular crowding condition.
Chen Z; Zheng KW; Hao YH; Tan Z
J Am Chem Soc; 2009 Aug; 131(30):10430-8. PubMed ID: 19588966
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of new benzimidazole-carbazole conjugates for the stabilization of human telomeric DNA, telomerase inhibition, and their selective action on cancer cells.
Maji B; Kumar K; Kaulage M; Muniyappa K; Bhattacharya S
J Med Chem; 2014 Aug; 57(16):6973-88. PubMed ID: 25062468
[TBL] [Abstract][Full Text] [Related]
11. Dimeric 1,3-phenylene-bis(piperazinyl benzimidazole)s: synthesis and structure-activity investigations on their binding with human telomeric G-quadruplex DNA and telomerase inhibition properties.
Jain AK; Paul A; Maji B; Muniyappa K; Bhattacharya S
J Med Chem; 2012 Apr; 55(7):2981-93. PubMed ID: 22452380
[TBL] [Abstract][Full Text] [Related]
12. Telomere targeting with a novel G-quadruplex-interactive ligand BRACO-19 induces T-loop disassembly and telomerase displacement in human glioblastoma cells.
Zhou G; Liu X; Li Y; Xu S; Ma C; Wu X; Cheng Y; Yu Z; Zhao G; Chen Y
Oncotarget; 2016 Mar; 7(12):14925-39. PubMed ID: 26908447
[TBL] [Abstract][Full Text] [Related]
13. Conformational studies and solvent-accessible surface area analysis of known selective DNA G-Quadruplex binders.
Alcaro S; Artese A; Costa G; Distinto S; Ortuso F; Parrotta L
Biochimie; 2011 Aug; 93(8):1267-74. PubMed ID: 21699954
[TBL] [Abstract][Full Text] [Related]
14. Telomere inhibition and telomere disruption as processes for drug targeting.
Rezler EM; Bearss DJ; Hurley LH
Annu Rev Pharmacol Toxicol; 2003; 43():359-79. PubMed ID: 12540745
[TBL] [Abstract][Full Text] [Related]
15. New dimeric carbazole-benzimidazole mixed ligands for the stabilization of human telomeric G-quadruplex DNA and as telomerase inhibitors. A remarkable influence of the spacer.
Maji B; Kumar K; Muniyappa K; Bhattacharya S
Org Biomol Chem; 2015 Aug; 13(30):8335-48. PubMed ID: 26149178
[TBL] [Abstract][Full Text] [Related]
16. Interaction of G-quadruplexes with nonintercalating duplex-DNA minor groove binding ligands.
Jain AK; Bhattacharya S
Bioconjug Chem; 2011 Dec; 22(12):2355-68. PubMed ID: 22074555
[TBL] [Abstract][Full Text] [Related]
17. An evaluation cascade for G-quadruplex telomere targeting agents in human cancer cells.
Gunaratnam M; Neidle S
Methods Mol Biol; 2010; 613():303-13. PubMed ID: 19997892
[TBL] [Abstract][Full Text] [Related]
18. Selective interaction of ethidium derivatives with quadruplexes: an equilibrium dialysis and electrospray ionization mass spectrometry analysis.
Rosu F; De Pauw E; Guittat L; Alberti P; Lacroix L; Mailliet P; Riou JF; Mergny JL
Biochemistry; 2003 Sep; 42(35):10361-71. PubMed ID: 12950163
[TBL] [Abstract][Full Text] [Related]
19. Human telomerase inhibition by regioisomeric disubstituted amidoanthracene-9,10-diones.
Perry PJ; Reszka AP; Wood AA; Read MA; Gowan SM; Dosanjh HS; Trent JO; Jenkins TC; Kelland LR; Neidle S
J Med Chem; 1998 Nov; 41(24):4873-84. PubMed ID: 9822556
[TBL] [Abstract][Full Text] [Related]
20. A new steroid derivative stabilizes g-quadruplexes and induces telomere uncapping in human tumor cells.
Brassart B; Gomez D; De Cian A; Paterski R; Montagnac A; Qui KH; Temime-Smaali N; Trentesaux C; Mergny JL; Gueritte F; Riou JF
Mol Pharmacol; 2007 Sep; 72(3):631-40. PubMed ID: 17586599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
